Intelligence · Clinical Pipeline
Approved programs Pipeline Programs
ClinicalTrials.gov programs marked approved or launched in registry data.
- Programs
- 1,839
Quick answer
NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.
Top sponsors
- Chinese Academy of 207 programs
- First People's Hospital 186 programs
- Takeda 154 programs
- United Therapeutics Europe 121 programs
- BRIGHT MINDS BIOSCIENCES 116 programs
- Disc Medicine 103 programs
- George Institute for 83 programs
- Hospital Authority 60 programs
- Regeneron UK 60 programs
- Sinovac Research and 47 programs
- Teva Pharma 39 programs
- Pacira Ireland 36 programs
-
Group 1 Standard of Care
Pacira Ireland Limited
Retraction of Colostomy
1 trial -
Group A (the standard 2HRZE/4HR regimen)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
1 trial -
Group C : Saline + propofol group
Hospital Authority, Hong Kong
Urologic Surgery
1 trial -
Guanfacine hydrochloride (TAK-503)
Takeda
Attention Deficit Hyperactivity Disorder
1 trial -
Guilingji Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oligospermia
1 trial -
Guli capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Guselkumab
Janssen Cilag International NV
Arthritis, Psoriatic
3 trials -
Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL
Janssen-Cilag International N.V.
Psoriatic Arthritis
1 trial -
H1N1 influenza A Vaccine (PANFLU.1)
Sinovac Research and Development Co.,
Influenza
1 trial -
H1N1 influenza A Vaccine (Split virion), Inactivated
Sinovac Research and Development Co.,
Influenza
1 trial -
HALOPERIDOL, CLOZAPINE, TIAPRIDE, SERTINDOLE, PALIPERIDONE, OLANZAPINE, SULPIRIDE, ARIPIPRAZOLE, LURASIDONE, RISPERIDONE, AMISULPRIDE, CHLORPROMAZINE, PIMOZIDE, QUETIAPINE
Disc Medicine
HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation.
1 trial -
HTX-011
Heron Therapeutics
Analgesia
6 trials -
HTX-011
Heron Therapeutics
Postoperative Pain
8 trials -
HUMAN SERUM ALBUMIN, SODIUM CHLORIDE
The George Institute
descompensated hepatic cirrosis
1 trial -
HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.
The George Institute
Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).
1 trial -
HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE
The George Institute
Rheumatoid Arthritis
1 trial -
HYQVIA
Takeda
Primary Immunodeficiency Diseases (PID)
2 trials -
Haloperidol
United Therapeutics Europe Ltd
Migraine Headaches
1 trial -
Harvoni (Fixed dose combination ledipasvir/sofosbuvir)
BRIGHT MINDS BIOSCIENCES INC.
Hepatitis C
1 trial -
Healive (hepatitis A vacine(human diploid cell), inactivated)
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Healive+Healive
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Healive® Lot 1
Sinovac Research and Development Co.,
Hepatitis A
1 trial -
Heliox inspirate
United Therapeutics Europe Ltd
Work of Breathing
1 trial -
Hemlibra 150 mg/mL solution for injection
Hoffmann-La Roche
Severe or Moderate Hemophilia A
1 trial -
Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection, Hemlibra 150 mg/mL solution for injection
Disc Medicine
Congenital Haemophilia A
1 trial -
Hemodialysis with Polymethylmethacrylate Artificial Kidney
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Uremia
1 trial -
Henagliflozin Proline Tablets treatment
The First People's Hospital of Lianyungang
Diabetes Type 2
1 trial -
Hepatitis B vaccine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Hepatitis B Vaccination, HIV
1 trial -
Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient
Biocodex
Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))
1 trial -
Hidrathea 9 mg/ml colirio en solución, Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución
Wuhan Createrna Science and Technology Co., Ltd
Dry Eye Disease
1 trial -
High-dosage SARS-CoV-2 vaccine
Sinovac Research and Development Co.,
COVID-19
1 trial -
High-dosage of COVID-19 vaccine (Vero cell), Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
High-dose anrikefon
The First People's Hospital of Lianyungang
Laparoscopic Surgery
2 trials -
Honghe Fujie lotion
The First People's Hospital of Lianyungang
Bacterial Vaginitis
1 trial -
Humira 40 mg solution for injection in pre-filled pen, ORENCIA 125 mg solution for injection in pre-filled syringe, Enbrel 50 mg solution for injection in pre-filled syringe, Reumaflex 50 mg/ml soluzione iniettabile, siringa preriempita, ORENCIA 250 mg powder for concentrate for solution for infusion, Cosentyx 150 mg solution for injection in pre-filled syringe, Enbrel 25 mg solution for injection in pre-filled syringe, Simponi 45 mg/0.45 mL solution for injection in pre-filled pen., Jylamvo 2 mg/ml oral so
Istituto Gentili S.r.l.
Juvenile idiopathic arthritis
1 trial -
Hydrocortisone Acetate 1% Ointment
BRIGHT MINDS BIOSCIENCES INC.
Postoperative Sore Throat, Cough, Hoarseness
1 trial -
Hydroxychloroquine Sulfate
The First People's Hospital of Lianyungang
Primary IgA Nephropathy
1 trial -
Hydroxychloroquine Sulfate 200 Mg Tablet
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Hylenex
HALOZYME THERAPEUTICS, INC.
Healthy
2 trials -
Hyperbaric bupivacaine+Sufentanil
Lxo Ireland Designated Activity Company
Anesthesia; Functional
1 trial -
Hypo-osmolar ORS
United Therapeutics Europe Ltd
Diarrhoea
1 trial -
ICD Ablation plus VT-ablation
Rhythm Pharmaceuticals Netherlands B.V.
Tachycardia, Ventricular
1 trial -
ICS+LABA
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis
1 trial -
ICS/LABA
The First People's Hospital of Lianyungang
Asthma
1 trial -
IIV4 and PPV23
BRIGHT MINDS BIOSCIENCES INC.
Influenza, Human
1 trial -
ILUVIEN
ANI PHARMACEUTICALS INC
Chronic Diabetic Macular Edema
1 trial -
ILUVIEN 0.19 MG
ANI PHARMACEUTICALS INC
Diabetic Macular Edema (DME)
1 trial -
IMATINIB , PONATINIB , BOSUTINIB, NILOTINIB, DASATINIB
Disc Medicine
Chronic myeloid leukaemia
1 trial
Frequently asked questions
How many Approved programs pipeline programs are in the directory?
1,839 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs